1-9 of 9
Howard H. Bailey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery

Available to Purchase
Tracy M. Downs, Howard H. Bailey, Taja Lozar, Natalie S. Schmitz, Heather Green, Cameron O. Scarlett, Thomas C. Havighurst, Kyleigh Twaroski, Katina DeShong, Barbara Wollmer, Trinity J. Bivalacqua, Daniel R. Saltzstein, Neal Shore, KyungMann Kim, Wei Huang, William A. Ricke, Lisa Barroilhet, Margaret House, Howard L. Parnes, Edward Messing
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2025) 18 (1): 31–39.
https://doi.org/10.1158/1940-6207.CAPR-24-0194
Published: 06 January 2025
View articletitled, Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery
Open the PDF for Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery in another window
Journal Articles

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers

Free
Jill M. Kolesar, Shannon Andrews, Heather Green, Tom C. Havighurst, Barbara W. Wollmer, Katina DeShong, Douglas E. Laux, Helen Krontiras, Donald D. Muccio, KyungMann Kim, Clinton J. Grubbs, Margaret G. House, Howard L. Parnes, Brandy M. Heckman-Stoddard, Howard H. Bailey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2019) 12 (12): 903–912.
https://doi.org/10.1158/1940-6207.CAPR-19-0310
Published: 03 December 2019
View articletitled, A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers
Open the PDF for A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers in another window
Journal Articles

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers

Free
Jason R. Gee, Daniel R. Saltzstein, KyungMann Kim, Jill Kolesar, Wei Huang, Thomas C. Havighurst, Barbara W. Wollmer, Jeanne Stublaski, Tracy Downs, Hasan Mukhtar, Margaret G. House, Howard L. Parnes, Howard H. Bailey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (5): 298–307.
https://doi.org/10.1158/1940-6207.CAPR-16-0167
Published: 01 May 2017
View articletitled, A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers
Open the PDF for A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers in another window
Journal Articles

Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer

Free
Carol J. Fabian, Bruce F. Kimler, Carola M. Zalles, Teresa A. Phillips, Trina Metheny, Brian K. Petroff, Thomas C. Havighurst, KyungMann Kim, Howard H. Bailey, Brandy M. Heckman-Stoddard
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (12): 1146–1155.
https://doi.org/10.1158/1940-6207.CAPR-15-0109
Published: 03 December 2015
View articletitled, Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer
Open the PDF for Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PR-10: Randomized placebo controlled trial of pioglitazone for oral premalignant lesions: A cross-consortium collaborative study in progress

Free
Jay O. Boyle, Frank G. Ondrey, Powel H. Brown, Howard H. Bailey, Kyung Mann Kim, Adel K. El-Naggar, Eva M. Szabo
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): PR-10.
https://doi.org/10.1158/1940-6207.PREV-10-PR-10
Published: 24 October 2014
View articletitled, Abstract PR-10: Randomized placebo controlled trial of pioglitazone for oral premalignant lesions: A cross-consortium collaborative study in progress
Journal Articles

Abstract A73: Randomized placebo-controlled trial of pioglitazone for oral premalignant lesions: A cross-consortium collaborative study in progress

Free
Jay O. Boyle, Frank G. Ondrey, Powel H. Brown, Howard H. Bailey, KyungMann Kim, Adel K. El-Naggar, Eva M. Szabo
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): A73.
https://doi.org/10.1158/1940-6207.PREV-10-A73
Published: 24 October 2014
View articletitled, Abstract A73: Randomized placebo-controlled trial of pioglitazone for oral premalignant lesions: A cross-consortium collaborative study in progress
Journal Articles

Abstract A52: A phase III skin cancer chemoprevention study of DFMO in subjects with a history of non-melanoma skin cancer (NMSC): Follow-up of NMSC events greater than 5 years post-study participation

Free
Sarah M. Lamont, Kyungmann Kim, Thomas Havighurst, Eneida Mendonça, Gary S. Wood, Stephen Snow, Howard H. Bailey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A52.
https://doi.org/10.1158/1940-6207.PREV-11-A52
Published: 23 October 2014
View articletitled, Abstract A52: A phase III skin cancer chemoprevention study of DFMO in subjects with a history of non-melanoma skin cancer (NMSC): Follow-up of NMSC events greater than 5 years post-study participation
Journal Articles

A Phase III Skin Cancer Chemoprevention Study of DFMO: Long-term Follow-up of Skin Cancer Events and Toxicity

Free
Sarah M. Kreul, Tom Havighurst, KyungMann Kim, Eneida A. Mendonça, Gary S. Wood, Stephen Snow, Abbey Borich, Ajit Verma, Howard H. Bailey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (12): 1368–1374.
https://doi.org/10.1158/1940-6207.CAPR-12-0233
Published: 04 December 2012
View articletitled, A Phase III Skin Cancer Chemoprevention Study of DFMO: Long-term Follow-up of Skin Cancer Events and Toxicity
Open the PDF for A Phase III Skin Cancer Chemoprevention Study of DFMO: Long-term Follow-up of Skin Cancer Events and Toxicity in another window
Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer

Free
Howard H. Bailey, KyungMann Kim, Ajit K. Verma, Karen Sielaff, Paul O. Larson, Stephen Snow, Theresa Lenaghan, Jaye L. Viner, Jeff Douglas, Nancy E. Dreckschmidt, Mary Hamielec, Marcy Pomplun, Harry H. Sharata, David Puchalsky, Eric R. Berg, Thomas C. Havighurst, Paul P. Carbone
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (1): 35–47.
https://doi.org/10.1158/1940-6207.CAPR-09-0096
Published: 04 January 2010
View articletitled, A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer
Open the PDF for A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer in another window
Includes: Supplementary data